BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ortiz Zacarías NV, Chahal KK, Šimková T, van der Horst C, Zheng Y, Inoue A, Theunissen E, Mallee L, van der Es D, Louvel J, IJzerman AP, Handel TM, Kufareva I, Heitman LH. Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2. J Med Chem 2021;64:2608-21. [PMID: 33600174 DOI: 10.1021/acs.jmedchem.0c01137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 den Hollander LS, Béquignon OJM, Wang X, van Wezel K, Broekhuis J, Gorostiola González M, de Visser KE, IJzerman AP, van Westen GJP, Heitman LH. Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism. Biochem Pharmacol 2023;208:115399. [PMID: 36581051 DOI: 10.1016/j.bcp.2022.115399] [Reference Citation Analysis]
2 Huber ME, Toy L, Schmidt MF, Weikert D, Schiedel M. Small Molecule Tools to Study Cellular Target Engagement for the Intracellular Allosteric Binding Site of GPCRs. Chemistry 2023;29:e202202565. [PMID: 36193681 DOI: 10.1002/chem.202202565] [Reference Citation Analysis]
3 Toy L, Huber ME, Schmidt MF, Weikert D, Schiedel M. Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2. ACS Chem Biol 2022. [PMID: 35838163 DOI: 10.1021/acschembio.2c00263] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Singh I, Seth A, Billesbølle CB, Braz J, Rodriguiz RM, Roy K, Bekele B, Craik V, Huang X, Boytsov D, Lak P, O’donnell H, Sandtner W, Roth BL, Basbaum AI, Wetsel WC, Manglik A, Shoichet BK, Rudnick G. Structure-based Discovery of Conformationally Selective Inhibitors of the Serotonin Transporter.. [DOI: 10.1101/2022.06.13.495991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Billen M, Schols D, Verwilst P. Targeting chemokine receptors from the inside-out: discovery and development of small-molecule intracellular antagonists. Chem Commun (Camb) 2022;58:4132-48. [PMID: 35274633 DOI: 10.1039/d1cc07080k] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Ortiz Zacarías NV, Bemelmans MP, Handel TM, de Visser KE, Heitman LH. Anticancer opportunities at every stage of chemokine function. Trends Pharmacol Sci 2021;42:912-28. [PMID: 34521537 DOI: 10.1016/j.tips.2021.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]